Global Oncology Biomarker Market Growth (Status and Outlook) 2025-2031

September 2025 | 97 pages | ID: G7C6D387521EN
LP Information

Abstracts

According to this study, the global Oncology Biomarker market size will reach US$ million by 2031.

A biomarker is referred to as a traceable biomolecule, whose presence found in body fluids such as blood, serum, urine, and tumor fluid that indicates disease or an underlying condition such as cancer.

United States market for Oncology Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Oncology Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Oncology Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Oncology Biomarker players cover Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, F.Hoffmann-La Roche Ltd., Genomic Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Oncology Biomarker Industry Forecast” looks at past sales and reviews total world Oncology Biomarker sales in 2024, providing a comprehensive analysis by region and market sector of projected Oncology Biomarker sales for 2025 through 2031. With Oncology Biomarker sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Biomarker industry.

This Insight Report provides a comprehensive analysis of the global Oncology Biomarker landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncology Biomarker portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Biomarker market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Biomarker and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Biomarker.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Biomarker market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Stomach Cancer
• Others

Segmentation by Application:

• Diagnostics
• Drug Discovery And Development
• Prognostics
• Risk Assessment
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott Laboratories
• Bristol-Myers Squibb
• Eli Lilly and Company
• F.Hoffmann-La Roche Ltd.
• Genomic Health
• GlaxoSmithKline plc
• Novartis AG
• Merck & Co.
• Pfizer
• Qiagen N.V.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oncology Biomarker Market Size (2020-2031)
  2.1.2 Oncology Biomarker Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Oncology Biomarker by Country/Region (2020, 2024 & 2031)
2.2 Oncology Biomarker Segment by Type
  2.2.1 Lung Cancer
  2.2.2 Breast Cancer
  2.2.3 Colorectal Cancer
  2.2.4 Prostate Cancer
  2.2.5 Stomach Cancer
  2.2.6 Others
2.3 Oncology Biomarker Market Size by Type
  2.3.1 Oncology Biomarker Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Oncology Biomarker Market Size Market Share by Type (2020-2025)
2.4 Oncology Biomarker Segment by Application
  2.4.1 Diagnostics
  2.4.2 Drug Discovery And Development
  2.4.3 Prognostics
  2.4.4 Risk Assessment
  2.4.5 Others
2.5 Oncology Biomarker Market Size by Application
  2.5.1 Oncology Biomarker Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Oncology Biomarker Market Size Market Share by Application (2020-2025)

3 ONCOLOGY BIOMARKER MARKET SIZE BY PLAYER

3.1 Oncology Biomarker Market Size Market Share by Player
  3.1.1 Global Oncology Biomarker Revenue by Player (2020-2025)
  3.1.2 Global Oncology Biomarker Revenue Market Share by Player (2020-2025)
3.2 Global Oncology Biomarker Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ONCOLOGY BIOMARKER BY REGION

4.1 Oncology Biomarker Market Size by Region (2020-2025)
4.2 Global Oncology Biomarker Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oncology Biomarker Market Size Growth (2020-2025)
4.4 APAC Oncology Biomarker Market Size Growth (2020-2025)
4.5 Europe Oncology Biomarker Market Size Growth (2020-2025)
4.6 Middle East & Africa Oncology Biomarker Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Oncology Biomarker Market Size by Country (2020-2025)
5.2 Americas Oncology Biomarker Market Size by Type (2020-2025)
5.3 Americas Oncology Biomarker Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oncology Biomarker Market Size by Region (2020-2025)
6.2 APAC Oncology Biomarker Market Size by Type (2020-2025)
6.3 APAC Oncology Biomarker Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oncology Biomarker Market Size by Country (2020-2025)
7.2 Europe Oncology Biomarker Market Size by Type (2020-2025)
7.3 Europe Oncology Biomarker Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oncology Biomarker by Region (2020-2025)
8.2 Middle East & Africa Oncology Biomarker Market Size by Type (2020-2025)
8.3 Middle East & Africa Oncology Biomarker Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ONCOLOGY BIOMARKER MARKET FORECAST

10.1 Global Oncology Biomarker Forecast by Region (2026-2031)
  10.1.1 Global Oncology Biomarker Forecast by Region (2026-2031)
  10.1.2 Americas Oncology Biomarker Forecast
  10.1.3 APAC Oncology Biomarker Forecast
  10.1.4 Europe Oncology Biomarker Forecast
  10.1.5 Middle East & Africa Oncology Biomarker Forecast
10.2 Americas Oncology Biomarker Forecast by Country (2026-2031)
  10.2.1 United States Market Oncology Biomarker Forecast
  10.2.2 Canada Market Oncology Biomarker Forecast
  10.2.3 Mexico Market Oncology Biomarker Forecast
  10.2.4 Brazil Market Oncology Biomarker Forecast
10.3 APAC Oncology Biomarker Forecast by Region (2026-2031)
  10.3.1 China Oncology Biomarker Market Forecast
  10.3.2 Japan Market Oncology Biomarker Forecast
  10.3.3 Korea Market Oncology Biomarker Forecast
  10.3.4 Southeast Asia Market Oncology Biomarker Forecast
  10.3.5 India Market Oncology Biomarker Forecast
  10.3.6 Australia Market Oncology Biomarker Forecast
10.4 Europe Oncology Biomarker Forecast by Country (2026-2031)
  10.4.1 Germany Market Oncology Biomarker Forecast
  10.4.2 France Market Oncology Biomarker Forecast
  10.4.3 UK Market Oncology Biomarker Forecast
  10.4.4 Italy Market Oncology Biomarker Forecast
  10.4.5 Russia Market Oncology Biomarker Forecast
10.5 Middle East & Africa Oncology Biomarker Forecast by Region (2026-2031)
  10.5.1 Egypt Market Oncology Biomarker Forecast
  10.5.2 South Africa Market Oncology Biomarker Forecast
  10.5.3 Israel Market Oncology Biomarker Forecast
  10.5.4 Turkey Market Oncology Biomarker Forecast
10.6 Global Oncology Biomarker Forecast by Type (2026-2031)
10.7 Global Oncology Biomarker Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Oncology Biomarker Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Information
  11.1.2 Abbott Laboratories Oncology Biomarker Product Offered
  11.1.3 Abbott Laboratories Oncology Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abbott Laboratories Main Business Overview
  11.1.5 Abbott Laboratories Latest Developments
11.2 Bristol-Myers Squibb
  11.2.1 Bristol-Myers Squibb Company Information
  11.2.2 Bristol-Myers Squibb Oncology Biomarker Product Offered
  11.2.3 Bristol-Myers Squibb Oncology Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Bristol-Myers Squibb Main Business Overview
  11.2.5 Bristol-Myers Squibb Latest Developments
11.3 Eli Lilly and Company
  11.3.1 Eli Lilly and Company Company Information
  11.3.2 Eli Lilly and Company Oncology Biomarker Product Offered
  11.3.3 Eli Lilly and Company Oncology Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Eli Lilly and Company Main Business Overview
  11.3.5 Eli Lilly and Company Latest Developments
11.4 F.Hoffmann-La Roche Ltd.
  11.4.1 F.Hoffmann-La Roche Ltd. Company Information
  11.4.2 F.Hoffmann-La Roche Ltd. Oncology Biomarker Product Offered
  11.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 F.Hoffmann-La Roche Ltd. Main Business Overview
  11.4.5 F.Hoffmann-La Roche Ltd. Latest Developments
11.5 Genomic Health
  11.5.1 Genomic Health Company Information
  11.5.2 Genomic Health Oncology Biomarker Product Offered
  11.5.3 Genomic Health Oncology Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Genomic Health Main Business Overview
  11.5.5 Genomic Health Latest Developments
11.6 GlaxoSmithKline plc
  11.6.1 GlaxoSmithKline plc Company Information
  11.6.2 GlaxoSmithKline plc Oncology Biomarker Product Offered
  11.6.3 GlaxoSmithKline plc Oncology Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 GlaxoSmithKline plc Main Business Overview
  11.6.5 GlaxoSmithKline plc Latest Developments
11.7 Novartis AG
  11.7.1 Novartis AG Company Information
  11.7.2 Novartis AG Oncology Biomarker Product Offered
  11.7.3 Novartis AG Oncology Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Novartis AG Main Business Overview
  11.7.5 Novartis AG Latest Developments
11.8 Merck & Co.
  11.8.1 Merck & Co. Company Information
  11.8.2 Merck & Co. Oncology Biomarker Product Offered
  11.8.3 Merck & Co. Oncology Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Merck & Co. Main Business Overview
  11.8.5 Merck & Co. Latest Developments
11.9 Pfizer
  11.9.1 Pfizer Company Information
  11.9.2 Pfizer Oncology Biomarker Product Offered
  11.9.3 Pfizer Oncology Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Pfizer Main Business Overview
  11.9.5 Pfizer Latest Developments
11.10 Qiagen N.V.
  11.10.1 Qiagen N.V. Company Information
  11.10.2 Qiagen N.V. Oncology Biomarker Product Offered
  11.10.3 Qiagen N.V. Oncology Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Qiagen N.V. Main Business Overview
  11.10.5 Qiagen N.V. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oncology Biomarker Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oncology Biomarker Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lung Cancer
Table 4. Major Players of Breast Cancer
Table 5. Major Players of Colorectal Cancer
Table 6. Major Players of Prostate Cancer
Table 7. Major Players of Stomach Cancer
Table 8. Major Players of Others
Table 9. Oncology Biomarker Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Oncology Biomarker Market Size by Type (2020-2025) & ($ millions)
Table 11. Global Oncology Biomarker Market Size Market Share by Type (2020-2025)
Table 12. Oncology Biomarker Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Oncology Biomarker Market Size by Application (2020-2025) & ($ millions)
Table 14. Global Oncology Biomarker Market Size Market Share by Application (2020-2025)
Table 15. Global Oncology Biomarker Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Oncology Biomarker Revenue Market Share by Player (2020-2025)
Table 17. Oncology Biomarker Key Players Head office and Products Offered
Table 18. Oncology Biomarker Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Oncology Biomarker Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Oncology Biomarker Market Size Market Share by Region (2020-2025)
Table 23. Global Oncology Biomarker Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Oncology Biomarker Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Oncology Biomarker Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Oncology Biomarker Market Size Market Share by Country (2020-2025)
Table 27. Americas Oncology Biomarker Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas Oncology Biomarker Market Size Market Share by Type (2020-2025)
Table 29. Americas Oncology Biomarker Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas Oncology Biomarker Market Size Market Share by Application (2020-2025)
Table 31. APAC Oncology Biomarker Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Oncology Biomarker Market Size Market Share by Region (2020-2025)
Table 33. APAC Oncology Biomarker Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC Oncology Biomarker Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe Oncology Biomarker Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Oncology Biomarker Market Size Market Share by Country (2020-2025)
Table 37. Europe Oncology Biomarker Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe Oncology Biomarker Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa Oncology Biomarker Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Oncology Biomarker Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa Oncology Biomarker Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Oncology Biomarker
Table 43. Key Market Challenges & Risks of Oncology Biomarker
Table 44. Key Industry Trends of Oncology Biomarker
Table 45. Global Oncology Biomarker Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global Oncology Biomarker Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global Oncology Biomarker Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global Oncology Biomarker Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. Abbott Laboratories Details, Company Type, Oncology Biomarker Area Served and Its Competitors
Table 50. Abbott Laboratories Oncology Biomarker Product Offered
Table 51. Abbott Laboratories Oncology Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. Abbott Laboratories Main Business
Table 53. Abbott Laboratories Latest Developments
Table 54. Bristol-Myers Squibb Details, Company Type, Oncology Biomarker Area Served and Its Competitors
Table 55. Bristol-Myers Squibb Oncology Biomarker Product Offered
Table 56. Bristol-Myers Squibb Oncology Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Bristol-Myers Squibb Main Business
Table 58. Bristol-Myers Squibb Latest Developments
Table 59. Eli Lilly and Company Details, Company Type, Oncology Biomarker Area Served and Its Competitors
Table 60. Eli Lilly and Company Oncology Biomarker Product Offered
Table 61. Eli Lilly and Company Oncology Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Eli Lilly and Company Main Business
Table 63. Eli Lilly and Company Latest Developments
Table 64. F.Hoffmann-La Roche Ltd. Details, Company Type, Oncology Biomarker Area Served and Its Competitors
Table 65. F.Hoffmann-La Roche Ltd. Oncology Biomarker Product Offered
Table 66. F.Hoffmann-La Roche Ltd. Oncology Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. F.Hoffmann-La Roche Ltd. Main Business
Table 68. F.Hoffmann-La Roche Ltd. Latest Developments
Table 69. Genomic Health Details, Company Type, Oncology Biomarker Area Served and Its Competitors
Table 70. Genomic Health Oncology Biomarker Product Offered
Table 71. Genomic Health Oncology Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Genomic Health Main Business
Table 73. Genomic Health Latest Developments
Table 74. GlaxoSmithKline plc Details, Company Type, Oncology Biomarker Area Served and Its Competitors
Table 75. GlaxoSmithKline plc Oncology Biomarker Product Offered
Table 76. GlaxoSmithKline plc Oncology Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. GlaxoSmithKline plc Main Business
Table 78. GlaxoSmithKline plc Latest Developments
Table 79. Novartis AG Details, Company Type, Oncology Biomarker Area Served and Its Competitors
Table 80. Novartis AG Oncology Biomarker Product Offered
Table 81. Novartis AG Oncology Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Novartis AG Main Business
Table 83. Novartis AG Latest Developments
Table 84. Merck & Co. Details, Company Type, Oncology Biomarker Area Served and Its Competitors
Table 85. Merck & Co. Oncology Biomarker Product Offered
Table 86. Merck & Co. Oncology Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Merck & Co. Main Business
Table 88. Merck & Co. Latest Developments
Table 89. Pfizer Details, Company Type, Oncology Biomarker Area Served and Its Competitors
Table 90. Pfizer Oncology Biomarker Product Offered
Table 91. Pfizer Oncology Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Qiagen N.V. Details, Company Type, Oncology Biomarker Area Served and Its Competitors
Table 95. Qiagen N.V. Oncology Biomarker Product Offered
Table 96. Qiagen N.V. Oncology Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Qiagen N.V. Main Business
Table 98. Qiagen N.V. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Oncology Biomarker Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Biomarker Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oncology Biomarker Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oncology Biomarker Sales Market Share by Country/Region (2024)
Figure 8. Oncology Biomarker Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oncology Biomarker Market Size Market Share by Type in 2024
Figure 10. Oncology Biomarker in Diagnostics
Figure 11. Global Oncology Biomarker Market: Diagnostics (2020-2025) & ($ millions)
Figure 12. Oncology Biomarker in Drug Discovery And Development
Figure 13. Global Oncology Biomarker Market: Drug Discovery And Development (2020-2025) & ($ millions)
Figure 14. Oncology Biomarker in Prognostics
Figure 15. Global Oncology Biomarker Market: Prognostics (2020-2025) & ($ millions)
Figure 16. Oncology Biomarker in Risk Assessment
Figure 17. Global Oncology Biomarker Market: Risk Assessment (2020-2025) & ($ millions)
Figure 18. Oncology Biomarker in Others
Figure 19. Global Oncology Biomarker Market: Others (2020-2025) & ($ millions)
Figure 20. Global Oncology Biomarker Market Size Market Share by Application in 2024
Figure 21. Global Oncology Biomarker Revenue Market Share by Player in 2024
Figure 22. Global Oncology Biomarker Market Size Market Share by Region (2020-2025)
Figure 23. Americas Oncology Biomarker Market Size 2020-2025 ($ millions)
Figure 24. APAC Oncology Biomarker Market Size 2020-2025 ($ millions)
Figure 25. Europe Oncology Biomarker Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Oncology Biomarker Market Size 2020-2025 ($ millions)
Figure 27. Americas Oncology Biomarker Value Market Share by Country in 2024
Figure 28. United States Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Oncology Biomarker Market Size Market Share by Region in 2024
Figure 33. APAC Oncology Biomarker Market Size Market Share by Type (2020-2025)
Figure 34. APAC Oncology Biomarker Market Size Market Share by Application (2020-2025)
Figure 35. China Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 39. India Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Oncology Biomarker Market Size Market Share by Country in 2024
Figure 42. Europe Oncology Biomarker Market Size Market Share by Type (2020-2025)
Figure 43. Europe Oncology Biomarker Market Size Market Share by Application (2020-2025)
Figure 44. Germany Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 45. France Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Oncology Biomarker Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Oncology Biomarker Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Oncology Biomarker Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Oncology Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 58. APAC Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 59. Europe Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 61. United States Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 62. Canada Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 63. Mexico Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 64. Brazil Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 65. China Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 66. Japan Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 67. Korea Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 69. India Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 70. Australia Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 71. Germany Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 72. France Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 73. UK Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 74. Italy Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 75. Russia Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 76. Egypt Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 77. South Africa Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 78. Israel Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 79. Turkey Oncology Biomarker Market Size 2026-2031 ($ millions)
Figure 80. Global Oncology Biomarker Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Oncology Biomarker Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Oncology Biomarker Market Size 2026-2031 ($ millions)